Study on Late Course Accelerated Fractionated Irradiation Combined with Concurrent Chemotherapy for 93 Cases Esophagus Squamous Cell Carcinoma
MA Shenglu
Abstract
MA Shenglu
Abstract
Objective:To study the effect of radiotherapy combined with paclitaxel chemotherapy on esophageal cancer.Method:173 cases of esophageal cancer were divided into conventional radiotherapy(80 cases) to a total of 65-70 Gy;combined group with received the same radiotherapy as simple irradiation group plus chemotherapy with weekly paclitaxel.Both groups were followed up for 2 years.Result:The short-term results of radiotherapy combined with chemotherapy was better than that of radiotherapy alone.The difference between these two groups was statistically(P0.05).The one and two years survival rate were 87%,68.8% in combined.survival rate were 51.3%,32.5% in simple irradiation group.The survival rates in the combined group were thus much better than those in simple irradiation group(P0.05).Conclusion:Radiotherapy combined with chemotherapy for advanced esophageal cancer is effective and merits further study in the clinic.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To study the effect of radiotherapy combined with paclitaxel chemotherapy on esophageal cancer.Method:173 cases of esophageal cancer were divided into conventional radiotherapy(80 cases) to a total of 65-70 Gy;combined group with received the same radiotherapy as simple irradiation group plus chemotherapy with weekly paclitaxel.Both groups were followed up for 2 years.Result:The short-term results of radiotherapy combined with chemotherapy was better than that of radiotherapy alone.The difference between these two groups was statistically(P0.05).The one and two years survival rate were 87%,68.8% in combined.survival rate were 51.3%,32.5% in simple irradiation group.The survival rates in the combined group were thus much better than those in simple irradiation group(P0.05).Conclusion:Radiotherapy combined with chemotherapy for advanced esophageal cancer is effective and merits further study in the clinic.
Key concepts: Medicine, Radiation therapy, Esophagus, Chemotherapy, Paclitaxel, Esophageal cancer, Survival rate, Cancer